A detailed history of Rhenman & Partners Asset Management Ab transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 195,000 shares of IGMS stock, worth $3.37 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
195,000
Previous 195,000 -0.0%
Holding current value
$3.37 Million
Previous $1.88 Million 28.81%
% of portfolio
0.13%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$8.68 - $17.36 $43,400 - $86,800
-5,000 Reduced 2.5%
195,000 $1.88 Million
Q3 2023

Nov 13, 2023

SELL
$6.66 - $10.64 $3.66 Million - $5.85 Million
-550,000 Reduced 73.33%
200,000 $1.67 Million
Q3 2023

Nov 09, 2023

BUY
$6.66 - $10.64 $3.66 Million - $5.85 Million
550,000 Added 275.0%
750,000 $6.26 Million
Q2 2023

Aug 11, 2023

BUY
$8.86 - $14.0 $930,299 - $1.47 Million
105,000 Added 110.53%
200,000 $1.85 Million
Q1 2023

May 11, 2023

BUY
$13.74 - $25.76 $618,300 - $1.16 Million
45,000 Added 90.0%
95,000 $1.31 Million
Q4 2022

Feb 13, 2023

BUY
$15.45 - $26.02 $772,500 - $1.3 Million
50,000 New
50,000 $850,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.